# Hour 00: 00:00-00:59 - Continuous RTCT Cold Start

Released on 1 May 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Hour 00 marks the cold-start of the National 24/7 Continuous Real-Time
Clinical Trial. All four sites (SITE-A Houston, SITE-B Philadelphia,
SITE-C Boston, SITE-D Texas Medical Center) come online simultaneously at
00:00 UTC and begin streaming signals to the Paradigm Health aggregator. The
aggregator forwards validated endpoints to the FDA real-time interface as
defined in the 28 April 2026 RTCT announcement.

## Cross-Site Status at 00:00 UTC

| Site | Patients On-Site | Active Procedures | Robots Standby | Robots Active | Signal Link |
|------|------------------|-------------------|----------------|---------------|-------------|
| SITE-A | 6 | 0 | 29 | 0 | UP (latency 142 ms) |
| SITE-B | 4 | 0 | 29 | 0 | UP (latency 168 ms) |
| SITE-C | 3 | 0 | 29 | 0 | UP (latency 201 ms) |
| SITE-D | 2 | 0 | 29 | 0 | UP (latency 119 ms) |

Total network: 15 patients, 116 robot instances on standby, FDA stream live.

## New Patient Arrivals This Hour

| Patient ID | Site | Time | Age | Sex | Cancer Type | Stage | ECOG | Robot Needed |
|------------|------|------|-----|-----|-------------|-------|------|--------------|
| PAT-CONT-0001 | SITE-A | 00:08 | 64 | M | Mantle cell lymphoma (TRAVERSE analog) | II | 1 | Cobot biopsy (2) |
| PAT-CONT-0002 | SITE-C | 00:22 | 71 | F | Limited-stage SCLC (STREAM analog) | LS | 2 | Imaging (8) |
| PAT-CONT-0003 | SITE-A | 00:41 | 58 | M | NSCLC adenocarcinoma | IIIA | 1 | RT Motion-Tracking (7) |
| PAT-CONT-0004 | SITE-B | 00:55 | 49 | F | Soft-tissue sarcoma | III | 1 | Cobot biopsy (2) |

## Minute-Resolution Activity Log

```
00:00  All sites green. RTCT signal channels open. PSL baselines snapshotted.
00:01  Paradigm Health handshake confirmed at all 4 sites.
00:02  FDA real-time API ack received (TRAVERSE channel).
00:03  FDA real-time API ack received (STREAM-SCLC channel).
00:04  Background telemetry streaming. No patient activity.
00:05  COMPN-03 (SITE-A) entering passive monitoring for overnight pediatric.
00:06  Robot maintenance window opens at SITE-D (NEEDLE-02 calibration).
00:07  No events.
00:08  PAT-CONT-0001 check-in at SITE-A kiosk 1. eConsent re-verified.
00:09  PAT-CONT-0001 escorted to Biopsy Station 1. COBOT-01 wakes from standby.
00:10  COBOT-01 calibration sweep (40 s). Force sensors zeroed.
00:11  PAT-CONT-0001 positioned. Pre-procedure safety matrix complete.
00:12  Biopsy needle insertion. Force feedback nominal (1.4 N).
00:13-00:18  Biopsy collection (6 cores). Real-time signal: tissue_acquired=1.
00:19  COBOT-01 retracts. PAT-CONT-0001 to recovery bay 4 (SITE-A).
00:20  Tissue routed to digital path. RTCT endpoint streamed to FDA.
00:21  FDA ack received: signal_id=TRAVERSE-CONT-0001-BX01.
00:22  PAT-CONT-0002 check-in at SITE-C. STREAM-SCLC enrollment confirmed.
00:23-00:34 Imaging session IMAGE-01 (SITE-C). Liver/lung baseline scan.
00:35  Image quality 8.7/10. DICOM upload in progress.
00:36-00:40 PAT-CONT-0002 to recovery bay 2 (SITE-C). Stable.
00:41  PAT-CONT-0003 check-in at SITE-A. RT fraction 8 of 30 scheduled.
00:42-00:43 RTPOS-02 + TRACK-02 wake. Vault 2 prep.
00:44  PAT-CONT-0003 positioned in vault. Marker block applied.
00:45-00:54 Beam delivery. 2 Gy across 3 fields. Gating efficiency 95.1%.
00:55  PAT-CONT-0004 check-in at SITE-B. Sarcoma biopsy.
00:56  TRACK-02 beam-off. PAT-CONT-0003 exits vault.
00:57  COBOT-02 (SITE-B) wakes for PAT-CONT-0004.
00:58  Biopsy needle insertion at SITE-B. 1.6 N steady.
00:59  Hour 00 close. PSL snapshot logged. 4 RTCT endpoints streamed.
```

## Departures This Hour

None. All four hour-00 arrivals remain on-site in recovery / pre-procedure.

## Adverse Events

None this hour. All signals nominal. FDA stream confirmed clean for all 4
endpoints.

## Investigational Drug Administrations

None this hour. PAT-CONT-0003 receiving standard-of-care RT only.
TRAVERSE / STREAM-SCLC patients in baseline / biopsy phase.

## Cross-Site Utilization

- SITE-A: 4 robot-active minutes (COBOT-01, RTPOS-02, TRACK-02)
- SITE-B: 2 robot-active minutes (COBOT-02)
- SITE-C: 12 robot-active minutes (IMAGE-01)
- SITE-D: 0 robot-active minutes
- Network utilization: 0.5%

## Regulatory Compliance Notes

### ICH E6(R3) - Adaption
- Section 2.9.1: Real-time audit trail forwarded to Paradigm Health every 60 s.
- Section 4.2.1: Minute-resolution data capture across all sites synchronized
  via UTC NTP stratum 1.

### 21 CFR Part 50 - Adaption
- Section 50.25: All 4 new patients had pre-existing continuous-trial eConsent
  including the RTCT signal-sharing addendum (added per FDA April 2026).
- Section 50.30: Pre-procedure safety matrix complete for COBOT-01, IMAGE-01,
  TRACK-02, COBOT-02.

### 21 CFR Part 312 - Adaption
- Section 312.32: No reportable events. FDA real-time channel verified open.
- Section 312.62: Investigator records updated within 15 min of each event.

## RTCT Signal Stream Summary

| Signal ID | Patient | Endpoint | Latency to FDA |
|-----------|---------|----------|----------------|
| TRAVERSE-CONT-0001-BX01 | PAT-CONT-0001 | Tissue acquired | 13 s |
| STREAM-CONT-0002-IMG01 | PAT-CONT-0002 | Baseline imaging complete | 14 s |
| TRAVERSE-CONT-0003-RT08 | PAT-CONT-0003 | RT fraction 8 delivered | 11 s |
| TRAVERSE-CONT-0004-BX01 | PAT-CONT-0004 | Tissue acquired | (in progress at 00:59) |
